Back to search

Article

Toward Early Diagnosis and Therapeutic Discovery in CLN3 Disease: A Computational Biomarker Discovery Framework

2026-05-07

Abstract excerpt

<h4>Background</h4> CLN3 disease, also known as juvenile neuronal ceroid lipofuscinosis, is a rare and neurodegenerative disorder characterized by the accumulation of lipopigments in the cells, progressive cognitive decline, seizures, and vision loss. Biomarker discovery in CLN3 disease is essential for enabling early and accurate diagnosis, which is critical given its neurodegenerative course. Biomarkers provide...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ea80d77-e4e3-5dc6-a032-7769e38a1c27
DOI
10.64898/2026.05.01.26352147
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Toward Early Diagnosis and Therapeutic Discovery in CLN3 Disease: A Computational Biomarker Discovery FrameworkDOI 10.64898/2026.05.01.26352147
Analysis of Potential Biomarkers and Modifier Genes Affecting the Clinical Course of CLN3 DiseaseSemantic proximity
A diagnostic confidence scheme for CLN3 disease.Semantic proximity
Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1Semantic proximity
Recent insights into the networking of CLN genes and proteins in mammalian cells.Semantic proximity
Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1Semantic proximity
Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's diseaseSemantic proximity
CLN3, at the crossroads of endocytic trafficking.Semantic proximity
A Timeline of Symptom Onset and Disease Progression in CLN3 DiseaseSemantic proximity
Computational drug repurposing identifies <i>N</i> -acetylglucosamine as a potential therapeutic compound for CLN3 Batten diseaseSemantic proximity
Molecular Biomarkers in Neurological Diseases: Advances in Diagnosis and PrognosisSemantic proximity
<i>CLN3</i> transcript complexity revealed by long-read RNA sequencing analysisSemantic proximity
A novel deletion variant in CLN3 with highly variable expressivity is responsible for juvenile neuronal ceroid lipofuscinoses.Semantic proximity
Select a neighboring publication to make it the new centre.